Allspring Large Cap Growth Fund Q4 2025 Performance Update

Allspring Global Investments33 FollowersFollow5ShareSavePlay(8min)CommentsSummaryThe Allspring Large Cap Growth Fund underperformed the Russell 1000 Growth Index during the fourth quarter.As VYVGART gains traction with new patients, argenx continues to advance its pipeline, targeting additional autoimmune disorders to further broaden its impact.With a record backlog and a global footprint, we believe that Johnson Controls is well positioned to capitalize on demand for energy-efficient solutions, digital building automation, and data center investments.With improving profitability and clarity on large deals, we believe Oracle can reestablish itself as an AI front-runner. arthon meekodong/iStock via Getty Images The following segment was excerpted from the Allspring Large Cap Growth Fund Q4 2025 Commentary. Performance and attribution Contributors argenx SE Johnson Controls S&P Global Inc. Microsoft Corp. McKesson Corp. (MCK) Detractors Oracle This article was written byAllspring Global Investments33 FollowersFollowAllspring is a company committed to thoughtful investing, purposeful planning, and the desire to elevate investing to be worth more. Allspring is reimagining investment management to be worth more—creating an investment, distribution, and operational experience that changes the game for clients. Note: This account is not managed or monitored by Allspring, and any messages sent via Seeking Alpha will not receive a response. For inquiries or communication, please use Allspring's official channels.